20th annual European Pharmaceutical Pricing and Reimbursement

Date: 13-Oct-14 to 14-Oct-14
Location: Marriott Regents Park Hotel / London / United Kingdom
Category: Healthcare & Pharmaceuticals Insurance Legal Services Science Conferences & Trade Fairs World & Regional

Market access remains one of the most significant current and future challenges for the industry. Spiralling drug development costs exert pressure to ensure successful and effective planning of your access strategies. With up to $5 billion in R&D costs for every successful drug launched, winning strategies are critical . Understanding the strengths and shortcomings in your people, processes and evidence are going to be the keys to your success. Planning around these key factors will enable increased market share for your organisation .

This year's conference will be held on 13-14 October. Now in its 20th year, this event has been one of the oldest market leaders in the pharmaceutical industries calendar for some time. Our expert speaking faculty; made up from key industry personnel from big pharma, biotech and academia will thoroughly explain and offer advice on P&R and market access. The 2014 agenda will focus on case studies as applied to different countries and environments in terms of market access.

Key Presenters Include:
Chairs for 2014:
• Peter Hertzman, Nordic Market Access Director, BMS
• Leslie Galloway, Chairman, Ethical Medicines Industry Group (EMIG)

Key Speakers:
• Leyla Hannbeck, Head of Pharmacy Services, National Pharmacy Association
• Silke Baumann, Head of Unit, Pricing, Assessment and Reimbursement of New Medicines, Ministry of Health, Germany
• Rodolphe Perard, Associate Director, Market Access, Gilead
• Francois Bernard, Head of Market Access, Mundipharma
• Mike Chambers, Head of Reimbursement and Value, Market Access and Healthcare Solutions, GlaxoSmithKline
• Linda Van Saase, Manager, Pharmaceutical Care, National Healthcare Institute
• Irma Van Den Arend, VP, Global Pricing, Reimbursement and Funding, Ipsen
• Mete Saylan, Senior Market Access Manager, Novartis
Benefits of Attending:
• Evaluate challenges within price discrimination
• Implications of AMNOG featuring IGES institut, EUCOPE and Ministry of Health, Germany
• Case study from Ipsen on latest developments in pharmaceutical pricing
• Analyse the impact of Value Based Assessment on SMEs
• Gain further insight on how to engage effectively with payers
• Key presentation on the IMI GetReal Consortium
• Ample networking opportunities , including a drinks reception on the close of Day One sponsored by Quintiles

For full conference programme please visit:
http://www.smi-online.co.uk/2014europricing9.asp
For more information please contact: Daniel Lee on +44(0) 207 827 6078 | dlee@smi-online.co.uk

Visitors

Market Access
Launch Excellence
Pricing and Reimbursement
Marketing (Consumer, Relationship, Multi channel,Strategic)
Project Management
Value Based Pricing
Business Development

Exhibitors

Market Access
Launch Excellence
Pricing and Reimbursement
Marketing (Consumer, Relationship, Multi channel,Strategic)
Project Management
Value Based Pricing
Business Development

Go to event website